Private Advisor Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Private Advisor Group’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-880	Closed	-$8K	–	2102
2023 Q1	$8K	Buy	880 +3	+0.3%	+$43	﹤0.01%	1947
2022 Q4	$10	Hold	877	–	–	﹤0.01%	1657
2022 Q3	$19K	Sell	877 -9	-1%	-$243	﹤0.01%	1876
2022 Q2	$21K	Sell	886 -233	-21%	-$7.93K	﹤0.01%	2074
2022 Q1	$56K	Hold	1,119	–	–	﹤0.01%	2037
2021 Q4	$79K	Buy	1,119 +33	+3%	+$2.78K	﹤0.01%	2049
2021 Q3	$101K	Sell	1,086 -50	-4%	-$4.75K	﹤0.01%	1946
2021 Q2	$114K	Sell	1,136 -192	-14%	-$18.7K	﹤0.01%	1896
2021 Q1	$124K	Buy	1,328 +91	+7%	+$9.23K	﹤0.01%	1790
2020 Q4	$102K	Buy	1,237 +72	+6%	+$6.14K	﹤0.01%	1685
2020 Q3	$100K	Buy	1,165 +458	+65%	+$53.4K	﹤0.01%	1489
2020 Q2	$66K	Buy	+707	New	+$39K	﹤0.01%	1942
2019 Q4	–	Sell	-367	Closed	-$5K	–	1755
2019 Q3	$5K	Buy	+367	New	+$7.68K	﹤0.01%	1652

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Private Advisor Group's VBIV Position: Q2 2023 in Review

Private Advisor Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 880 shares — an estimated $8K sold.

Private Advisor Group first reported a position in VBIV in Q3 2019 and held it in 13 quarters. The position peaked at $124K in Q1 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Private Advisor Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Private Advisor Group sold 880 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $8K.
Private Advisor Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 13 quarters.
Private Advisor Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $124K in Q1 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Private Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.